Documentos relacionados

1. Functional investigation of two simultaneous or separately segregating DSP variants within a single family supports the theory of a dose-dependent disease severity.
2. Desmoplakin and clinical manifestations of desmoplakin cardiomyopathy.
3. A novel desmoplakin mutation causes dilated cardiomyopathy with palmoplantar keratoderma as an early clinical sign.
4. A new de novo heterozygous missense mutation in the desmoplakin gene, causing Naxos and Carvajal disease, associating oligodontia and nail fragility.
5. Epidermal growth factor receptor inhibition leads to cellular phenotype correction of DSP-mutated keratinocytes.
6. A truncating variant altering the extreme C-terminal region of desmoplakin (DSP) suggests the crucial functional role of the region: a case report study.
7. Two Novel Homozygous Desmoplakin Mutations in Carvajal Syndrome.
8. Loss-of-function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.
9. Early-onset heart failure, alopecia, and cutaneous abnormalities associated with a novel compound heterozygous mutation in desmoplakin.
10. Nagashima-type palmoplantar keratoderma: Case series and two novel variants.